USA antimicrobial susceptibility testing market is characterized by the presence of leading diagnostics and life sciences companies focused on delivering rapid, reliable, and scalable solutions.
For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...
Rapid antimicrobial susceptibility testing for gram-negative blood infections shows no improvement in clinical outcomes ...
The US Food and Drug Administration (FDA) on Wednesday launched a new website aimed at improving access to information that can help healthcare professionals determine which drugs are most likely to ...
MedPage Today on MSN
Does Rapid Antimicrobial Testing for Gram-Negative Bacteremia Improve Outcomes?
Trial comes up negative, but shorter hospital stays observed in carbapenem-resistant cases ...
LONDON--(BUSINESS WIRE)--Technavio’s latest market research report on the global antimicrobial susceptibility testing market (AST) forecasts the market to witness a CAGR of over 5% during the forecast ...
The field of antimicrobial susceptibility testing (AST) and resistance detection is rapidly evolving to address the global threat posed by antimicrobial resistance. In recent years, a ...
In a paper published online this week the scientists reported the development of a rapid susceptibility test for Staphylococcus aureus, a bacterium that causes some 60 percent of hospital-acquired ...
In recent years, many efforts have been undertaken to establish new methods for DST to be used on a routine level. The epidemiology of drug-resistant and MDR-TB has posed an enormous need for faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results